Utvärdering av tularemispecifik diagnostik
No Thumbnail Available
Date
2025-07-15
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Background. Tularemia is a zoonotic infection caused by the bacterium Francisella
tularensis. Laboratory diagnosis consists primarily of serological methods. Enzyme-
linked immunosorbent assay (ELISA) is performed at the Laboratory Medicine,
Norrland’s University Hospital in Umeå. A rapid serological test, Virapid tularemia,
is also used there and at the Laboratory Medicine, Östersund ́s Hospital. It is
considered important to compare Virapid with ELISA as this has not been done
previously on this material.
Research question. How well does Virapid agree with ELISA? To what extent are
there clinical indications for current tularemia when the result of Virapid and/or
ELISA is positive? Is the result for either test (Virapid and ELISA) better than the
other in detecting a current infection with tularemia?
Materials and methods. In total, 2443 serum samples analyzed between 2011 and
2025 at Norrland’s University Hospital and 304 serum samples analyzed at
Östersund ́s hospital between 2022 and 2025 were included. For all samples,
simultaneous analysis had been performed with Virapid and ELISA. Sixty-two
patient records were reviewed to determine correlation to current tularemia.
Results. In the Umeå material, the sensitivity for Virapid in comparison with ELISA
was 55.8% and the specificity was 93.9%. The corresponding values in the
Östersund material were 67.9% and 92.8%. A comparison was made between
ELISA and Virapid in relation to current tularemia with similar outcomes; the
former assay showed a sensitivity of 88.9% and a specificity of 87.1% and the latter
83,3% and 86,4%, respectively.
Conclusion. A relatively large discrepancy was seen between Virapid and ELISA.
For both ELISA and Virapid, there were positive samples that did not correlate to a
current infection. The result indicates that borderline responses for ELISA have low
predictive value. Larger studies are required to further investigate how Virapid and
ELISA relate to each other and to current tularemia.
Description
Keywords
Tularemia